| Literature DB >> 27649134 |
Chih-Hua Chao1,2, Ying-Ju Lin3,4, Ju-Chien Cheng5, Hui-Chi Huang6, Yung-Ju Yeh7, Tian-Shung Wu8,9, Syh-Yuan Hwang10, Yang-Chang Wu11,12,13,14.
Abstract
In an attempt to study the chemical constituents from the twigs and leaves of Flueggea virosa, a new terpenoid, 9(10→20)-abeo-ent-podocarpane, 3β,10α-dihydroxy-12-methoxy-13- methyl-9(10→20)-abeo-ent-podocarpa-6,8,11,13-tetraene (1), as well as five known compounds were characterized. Their structures were elucidated on the basis of spectroscopic analysis. In addition, the structure of dehydrochebulic acid trimethyl ester was revised as (2S,3R)-4E-dehydrochebulic acid trimethyl ester based on a single-crystal X-ray diffraction study. The in vitro anti-hepatitis C virus (anti-HCV) activity and cytotoxicity against Huh7.5 cells for the isolated compounds were evaluated.Entities:
Keywords: Flueggea virosa; HCVcc; anti-HCV; dehydrochebulic acid trimethyl ester; ent-podocarpane
Mesh:
Substances:
Year: 2016 PMID: 27649134 PMCID: PMC6274521 DOI: 10.3390/molecules21091239
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Chart 1Structures of compounds 1–6.
1H- and 13C-NMR Spectroscopic Data (400 and 100 MHz, resp.; CDCl3) of 1.
| 1 | |||
|---|---|---|---|
| δH ( | δC (Mult.) | HMBC | |
| 1 | 2.05 td (14.1, 4.4) | 33.0 (CH2) | 2, 3, 20 |
| 1.61 m | |||
| 2 | 2.27 m | 25.5 (CH2) | 1 |
| 1.62 m | |||
| 3 | 3.51 t (2.8) | 75.6 (CH) | 1, 5 |
| 4 | 38.2 (C) | ||
| 5 | 2.45 dd (4.4, 2.6) | 49.6 (CH) | 4, 6, 7, 10, 18, 19 |
| 6 | 5.78 dd (12.1, 4.4) | 128.0 (CH) | 4, 5, 8, 10 |
| 7 | 6.58 dd (12.1, 2.6) | 131.3 (CH) | 5, 9, 14 |
| 8 | 128.4 (C) | ||
| 9 | 135.2 (C) | ||
| 10 | 76.4 (C) | ||
| 11 | 6.56 s | 112.2 (CH) | 8, 12, 13, 20 |
| 12 | 156.9 (C) | ||
| 13 | 124.4 (C) | ||
| 14 | 6.95 s | 132.4 (CH) | 7, 9, 12 |
| 15 | 2.17 s | 15.6 (CH3) | 12, 13, 14 |
| 18 | 1.00 s | 27.2 (CH3) | 3, 4, 5, 19 |
| 19 | 1.09 s | 22.4 (CH3) | 3, 4, 5, 18 |
| 20 | 2.96 d (14.2) | 51.6 (CH2) | 1, 5, 8, 9, 10, 11 |
| 2.68 d (14.2) | |||
| 12-OMe | 3.82 s | 55.3 (CH3) | 12 |
Figure 1Selected 1H−1H COSY (▬) and HMBC (→) correlations of 1.
Figure 2Selected NOE correlations of 1.
Figure 3(a) 1H-NMR spectrum of 2 measured in acetone-d6 and (b) selective 1D NOESY spectrum of 2: selective irradiation of H-5 (δH = 6.83 ppm) using selnogp.3 Bruker program (parameter set: ns 128, p12 = 80 ms, and d8 = 400 ms).
Figure 4X-ray ORTEP drawing of 2.
Anti-HCV activities (EC50) and cytotoxicity (IC50) of 1–6.
| Compound | EC50 (μM) a | IC50 (μM) b | (TI) c |
|---|---|---|---|
| 27.4 ± 1.4 | >100 | - d | |
| 98.4 ± 2.1 | >100 | - d | |
| 12.8 ± 3.1 | 87.1 ± 5.1 | 6.8 | |
| 7.7 ± 2.7 | 70.5 ± 4.2 | 9.2 | |
| 20.8 ± 2.0 | 60.7 ± 2.0 | 2.9 | |
| 66.7 ± 1.8 | >100 | - d | |
| honokiol | 22.4 ± 0.5 | 48.8 ± 0.8 | 2.1 |
a EC50: concentration that inhibits HCVcc infection by 50%. b IC50: concentration that inhibits cell growth by 50%. c Therapeutic index (TI) = IC50/EC50. d not calculated.